Order Article Reprints

Asdaq SMB, Rajan A, Damodaran A, Kamath SR, Nair KS, Zachariah SM, Sahu RK, Fattepur S, Sreeharsha N, Nair A, et al. Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention. Antibiotics. 2021; 10(11):1308. https://doi.org/10.3390/antibiotics10111308

Asdaq, Syed Mohammed Basheeruddin, Arya Rajan, Aswin Damodaran, Shivali R. Kamath, Krishnanjana S. Nair, Subin Mary Zachariah, Ram Kumar Sahu, Santosh Fattepur, Nagaraja Sreeharsha, Anroop Nair, and et al. 2021. "Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention" Antibiotics 10, no. 11: 1308. https://doi.org/10.3390/antibiotics10111308

Asdaq, S. M. B., Rajan, A., Damodaran, A., Kamath, S. R., Nair, K. S., Zachariah, S. M., Sahu, R. K., Fattepur, S., Sreeharsha, N., Nair, A., Jacob, S., Albahrani, H. A., Alkhaldi, E. H., Mohzari, Y., Alrashed, A. A., & Imran, M. (2021). Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention. Antibiotics, 10(11), 1308. https://doi.org/10.3390/antibiotics10111308